FDA Voices
Insights from FDA leadership and experts into the agency's work to protect public health.
Sub-Topic Paragraphs
Paragraph Header
FDA VOICES: PERSPECTIVES FROM FDA EXPERTS
CDER Continues to Make Rare Diseases a Priority with Drug Approvals and Programming to Speed Therapeutic Development
Over the past decade or so, we have seen an upward trajectory in the percentage of drugs approved to treat rare or “orphan” diseases.
Sharing Experiences in Rare Diseases Together
This year, the U.S. Food and Drug Administration is part of the worldwide community observing Rare Disease Week—February 28th through March 4th.
Some table information
Published Date | Image | Title | Detailed Description | Regulated Products | Health Topics (Hidden) |
---|